Glucotrack, Inc. — Form 8-K
Filed September 24, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 58/100
What the filing says
Glucotrack, Inc. (market cap ~$5.4M) is issuing 169,388 common shares at $2.04/share and pre-funded warrants to purchase up to 1,350,220 shares at $0.001/share, for aggregate gross proceeds of approximately $3,100,000. The offering is registered on Form S-3 (File No. 333-282297, effective October 3, 2024). Placement agent: Dawson James Securities, Inc. (8% placement fee). Closing date: September 24, 2026.
Why this rating
Gross proceeds (~$3.1M) equal ~57% of $5.4M market cap—material dilution. Moderate event: significant financing relative to company size, but ordinary equity raise mechanism with standard terms. No transformational deal or going-concern issue evident.
See more from September 24, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.